David Ege

David Ege

Company: Seres Therapeutics

Job title: Chief Technology Officer and Execvtive Vice President - Process Development, Quality & Supply


Vowst – The CMC Journey from Idea to FDA Approval 9:00 am

How to develop an FMT product and identify a CDMO to manufacture an orally-dosed, spore-forming drug Challenges to adapt a multi-product facility to support handling of bacterial spores and the complexities behind process and analytical development The journey to Phase III through PAI readiness, inspection and ramp up to commercial manufacturingRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.